Dr. Hindes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
24 Hospital Ave
Danbury, CT 06810Phone+1 203-797-7413
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1984 - 1987
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1980 - 1983
Rutgers Robert Wood Johnson Medical SchoolClass of 1980
Certifications & Licensure
CT State Medical License 1988 - 2024
NY State Medical License 1987 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 893 citationsDaclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infectionMark S. Sulkowski, David F. Gardiner, Maribel Rodriguez-Torres, K. Rajender Reddy, Tarek Hassanein
The New England Journal of Medicine. 2014-01-15 - 244 citationsSofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a rand...Eric Lawitz, J. Lalezari, Tarek Hassanein, Kris V. Kowdley, Fred Poordad
The Lancet. Infectious Diseases. 2013-05-01 - 227 citationsSofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): An open-label, randomised, mult...Kris V. Kowdley, Eric Lawitz, Israel Crespo, Tarek Hassanein, M. Davis
Lancet. 2013-06-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
